Select Page

M20-371 (AbbVie)

Study Drug: ABBV-154 Study Drug administration: IV and Subcutaneous Injection Principal Investigator: Jay Desai Disease: Moderate to Severe Crohn’s Disease Inclusion criteria: endoscopically and clinically active CD, failed biologics (biologic therapy include TNF...

EMERALD-1 (Morphic Therapeutic)

Study Drug: MORF-057 Study Drug administration: Oral Principal Investigator: Jay Desai Disease: Moderate to Severe Ulcerative Colitis Inclusion criteria: endoscopically and clinically active UC, treatment naïve OR failed biologics (include TNF antagonists,...